MTOR and cervical carcinoma: Our detection of frequent PI3K/AKT/mTOR pathway alterations in HPV+ tumors is consistent with a recent report demonstrating PI3K pathway activation and sensitivity to mTOR inhibition in both cervical carcinoma and HPV+ HNSCC [33].